Skyepharma Competitors and Similar CompaniesClear all

Skyepharma's competitors and similar companies include Avid Bioservices, Zogenix, Amicus Therapeutics and Societal CDMO.
Skyepharma
Skyepharma
Skyepharma is a drug delivery company developing oral and inhalation products.
Avid Bioservices
Avid Bioservices
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
Zogenix
Zogenix
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Societal CDMO
Societal CDMO
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
Founding Date
Founding Date
1996
Founding Date
1981
Founding Date
2006
Founding Date
2002
Founding Date
2006
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Saint-Quentin-Fallavier, FR HQ
Locations
Tustin, US HQ
Locations
Emeryville, US HQ
Maidenhead, GB
Locations
Philadelphia, US HQ
Northbridge, AU
Pointe Claire, CA
Paris, FR
München, DE
Dublin, IE
Milano, IT
see more
Locations
Gainesville, US HQ
Gainesville, US
San Diego, US
Employees
Employees
206
Employees
21114% increase
Employees
14157% increase
Employees
58415% increase
Employees
21316% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
529 m
Valuation ($)
N/A
Valuation ($)
3.1 b
Valuation ($)
116.1 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
2
Twitter followers
2.1 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
£95.9m (FY, 2015)
Revenue (est.)
$139.9m (FY, 2024)
Revenue (est.)
$81.7m (FY, 2021)
Revenue (est.)
$399.4m (FY, 2023)
Revenue (est.)
$94.6m (FY, 2023)
Cost of goods
Cost of goods
£43.1m (FY, 2015)
Cost of goods
$132.6m (FY, 2024)
Cost of goods
$4.8m (FY, 2021)
Cost of goods
$37.3m (FY, 2023)
Cost of goods
$76.5m (FY, 2023)
Gross profit
Gross profit
£52.8m (FY, 2015)
Gross profit
$7.3m (FY, 2024)
Gross profit
N/A
Gross profit
$362m (FY, 2023)
Gross profit
N/A
Net income
Net income
N/A
Net income
($140.8m) (FY, 2024)
Net income
($227.4m) (FY, 2021)
Net income
($151.6m) (FY, 2023)
Net income
($13.3m) (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

Avid Bioservices
HQ
Tustin, US
Employees
211↑ 14% increase

Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.

View company
Zogenix
HQ
Emeryville, US

Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.

View company
Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company
Societal CDMO
HQ
Gainesville, US
Employees
213↓ 16% decrease

Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.

View company